Reviva pharmaceuticals to present at the h.c. wainwright 24th annual global investment conference

Cupertino, calif., sept. 07, 2022 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will present at the h.c. wainwright global investment conference being held september 12–14, 2022 and invites investors to participate via virtual one-on-one meetings or in-person in new york, ny. please see additional details below:
RVPH Ratings Summary
RVPH Quant Ranking